Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02748564
Title Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cardinal Bernardin Cancer Center Maywood Illinois 60153 United States Details
Indiana University Bloomington Indiana 46996 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14203 United States Details
*Shaded cells indicate that there was no data available from for the field